$PIII
P3 Health Partners Inc. Stock $piii

$piii Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000110465923039643 Filed on March 31, 2023

Income Statement

Concept	2022 Q4	2022	2021 Q4
Revenue	$258.2M	$1.049B	$58.76M
YoY Change	339.42%	64.66%	-52.94%
Cost Of Revenue	$269.2M	$1.057B	$200.1M
YoY Change	34.52%	60.35%	45.79%
Gross Profit	-$10.97M	-$7.753M	-$22.25M
YoY Change	-50.71%	-64.72%	79.74%
Gross Profit Margin	-4.25%	-0.74%	-37.86%
Selling, General & Admin	$41.43M	$162.4M	$17.35M
YoY Change	138.81%	35.99%	-0.81%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$22.00M	$2.400M	$187.6K
YoY Change	11630.92%	-72.49%	3.14%
% of Gross Profit
Operating Expenses	$62.08M	$2.610B	$117.7M
YoY Change	-47.23%	1472.82%	-7621.42%
Operating Profit	-$73.05M	-$1.561B	-$58.89M
YoY Change	24.05%	730.51%	444.57%
Interest Expense	-$3.159M	-$11.40M	$2.131M
YoY Change	-248.23%	3.68%	-168.91%
% of Operating Profit
Other Income/Expense, Net	$9.236M	$1.218M	$949.7K
YoY Change	872.44%	-122.58%	-426.73%
Pretax Income	-$530.5M	-$1.560B	-$57.94M
YoY Change	815.58%	663.29%	308.1%
Income Tax	$1.862M	$1.862M	$0.00
% Of Pretax Income
Net Earnings	-$94.03M	-$270.1M	-$10.08M
YoY Change	832.69%	72.63%	-24.43%
Net Earnings / Revenue	-36.41%	-25.74%	-17.16%
Basic Earnings Per Share		-$6.50	-$0.24
Diluted Earnings Per Share	-$2.26	-$6.50	-$0.24
COMMON SHARES
Basic Shares Outstanding		41.58K	41.58M
Diluted Shares Outstanding		41.58K	41.58M

Balance Sheet

Concept	2022 Q4	2022	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.54M	$17.54M	$140.5M
YoY Change	-87.52%	-87.52%
Cash & Equivalents	$17.54M		$140.5M
Short-Term Investments
Other Short-Term Assets	$3.563M	$3.563M	$7.315M
YoY Change	-51.29%	-51.29%
Inventory
Prepaid Expenses			$355.2K
Receivables	$72.91M	$72.91M	$51.34M
Other Receivables	$6.678M	$6.678M	$726.9K
Total Short-Term Assets	$100.7M	$100.7M	$199.9M
YoY Change	-49.62%	-49.62%	50502.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.839M	$8.839M	$8.048M
YoY Change	9.83%	-41.34%	30.85%
Goodwill	$0.00		$1.310B
YoY Change	-100.0%		150251.06%
Intangibles	$751.1M		$835.8M
YoY Change	-10.14%
Long-Term Investments
YoY Change
Other Assets	$15.99M	$15.99M	$10.61M
YoY Change	50.69%
Total Long-Term Assets	$775.9M	$775.9M	$2.164B
YoY Change	-64.15%	-64.15%
TOTAL ASSETS
Total Short-Term Assets	$100.7M	$100.7M	$199.9M
Total Long-Term Assets	$775.9M	$775.9M	$2.164B
Total Assets	$876.6M	$876.6M	$2.364B
YoY Change	-62.92%	-62.92%	598469.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.54M	$174.8M	$124.5M
YoY Change	-90.73%	1017.13%
Accrued Expenses	$66.91M	$66.91M	$52.91M
YoY Change	26.45%	21.65%	2314469.99%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$3.579M
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$0.00	$0.00	$46.10K
YoY Change	-100.0%	-100.0%	-48.77%
Total Short-Term Liabilities	$241.7M	$241.7M	$198.8M
YoY Change	21.58%	21.58%	53298.41%
LONG-TERM LIABILITIES
Long-Term Debt	$94.42M	$94.42M	$80.00M
YoY Change	18.03%	18.03%	76.26%
Other Long-Term Liabilities	$17.83M	$17.83M	$21.17M
YoY Change	-15.78%	-15.78%
Total Long-Term Liabilities	$112.2M	$112.2M	$101.2M
YoY Change	10.95%	10.95%	82.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$241.7M	$241.7M	$198.8M
Total Long-Term Liabilities	$112.2M	$112.2M	$101.2M
Total Liabilities	$353.9M	$870.7M	$299.9M
YoY Change	17.99%	-58.35%	80475.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$309.5M		-$39.42M
YoY Change	685.29%		1724227.38%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.854M	$5.854M	$273.6M
YoY Change
Total Liabilities & Shareholders Equity	$876.6M	$876.6M	$2.364B
YoY Change	-62.92%	-62.92%	598469.09%

Cashflow Statement

Concept	2022 Q4	2022	2021 Q4
OPERATING ACTIVITIES
Net Income	-$94.03M	-$270.1M	-$10.08M
YoY Change	832.69%	72.63%	-24.43%
Depreciation, Depletion And Amortization	$22.00M	$2.400M	$187.6K
YoY Change	11630.92%	-72.49%	3.14%
Cash From Operating Activities	-$31.95M	-$126.0M	-$15.34M
YoY Change	108.28%	89.58%	-14.53%
INVESTING ACTIVITIES
Capital Expenditures	-$50.40K	$2.233M	$120.6K
YoY Change	-141.81%	-165.46%	-117.37%
Acquisitions
YoY Change
Other Investing Activities	$130.00	-$5.500M	-$47.76M
YoY Change	-100.0%	-89.55%	8196.58%
Cash From Investing Activities	$50.54K	-$7.733M	-$47.86M
YoY Change	-100.11%	-86.21%	3669.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$46.00K	$8.008K
YoY Change
Cash From Financing Activities	15.00M	11.38M	198.7M
YoY Change	-92.45%	-94.91%	471.21%
NET CHANGE
Cash From Operating Activities	-31.95M	-126.0M	-15.34M
Cash From Investing Activities	50.54K	-7.733M	-47.86M
Cash From Financing Activities	15.00M	11.38M	198.7M
Net Change In Cash	-16.90M	-126.0M	135.5M
YoY Change	-112.48%	-224.86%	770.6%
FREE CASH FLOW
Cash From Operating Activities	-$31.95M	-$126.0M	-$15.34M
Capital Expenditures	-$50.40K	$2.233M	$120.6K
Free Cash Flow	-$31.90M	-$128.3M	-$15.46M
YoY Change	106.33%	103.38%	-10.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
	us-gaap	Financial Designation Predecessor And Successor Fixed List FinancialDesignationPredecessorAndSuccessorFixedList	Predecessor
CY2021Q4	us-gaap	Financial Designation Predecessor And Successor Fixed List FinancialDesignationPredecessorAndSuccessorFixedList	Successor
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001832511
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	84200000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	84200000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	84200000
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AssetsNoncurrent
CY2021Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0
CY2021Q4	piii	Number Of Health Plans Percentage Of Payment Contracts Entered NumberOfHealthPlansPercentageOfPaymentContractsEntered	4
CY2021Q4	piii	Number Of Health Plans Percentage Of Payment Contracts Entered NumberOfHealthPlansPercentageOfPaymentContractsEntered	4
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-40033
CY2022	dei	Entity Registrant Name EntityRegistrantName	P3 Health Partners Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2992794
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	2370 Corporate Circle Suite 300
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Henderson
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89074
CY2022	dei	City Area Code CityAreaCode	702
CY2022	dei	Local Phone Number LocalPhoneNumber	910-3950
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	93000000
CY2022	dei	Auditor Name AuditorName	BDO USA, LLP
CY2022	dei	Auditor Location AuditorLocation	Las Vegas, Nevada
CY2022	dei	Auditor Firm AuditorFirmId	243
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17537000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	140478000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	920000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	356000
CY2022Q4	piii	Health Plan Settlement Receivables Current HealthPlanSettlementReceivablesCurrent	72092000
CY2021Q4	piii	Health Plan Settlement Receivables Current HealthPlanSettlementReceivablesCurrent	50251000
CY2022Q4	piii	Clinic Fees And Insurance Receivables Net Current ClinicFeesAndInsuranceReceivablesNetCurrent	822000
CY2021Q4	piii	Clinic Fees And Insurance Receivables Net Current ClinicFeesAndInsuranceReceivablesNetCurrent	1090000
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	6678000
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	727000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2643000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6959000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	100692000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	199861000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8839000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8048000
CY2021Q4	us-gaap	Goodwill Goodwill	1309750000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	751050000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	835839000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15990000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10611000
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	775879000
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2164248000
CY2022Q4	us-gaap	Assets Assets	876571000
CY2021Q4	us-gaap	Assets Assets	2364109000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11542000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5469000
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	16647000
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	12261000
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	8224000
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	6304000
CY2022Q4	piii	Health Plans Settlements Payable Current HealthPlansSettlementsPayableCurrent	13608000
CY2021Q4	piii	Health Plans Settlements Payable Current HealthPlansSettlementsPayableCurrent	22549000
CY2022Q4	piii	Claims Payable Current ClaimsPayableCurrent	151207000
CY2021Q4	piii	Claims Payable Current ClaimsPayableCurrent	101958000
CY2022Q4	piii	Premium Deficiency Reserve Current PremiumDeficiencyReserveCurrent	26375000
CY2021Q4	piii	Premium Deficiency Reserve Current PremiumDeficiencyReserveCurrent	37836000
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	14061000
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	8771000
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	46000
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	3579000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	241664000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	198773000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11516000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6297000
CY2022Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	1517000
CY2021Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	11383000
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	4794000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	3487000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	94421000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	80000000
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	112248000
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	101167000
CY2022Q4	us-gaap	Liabilities Liabilities	353912000
CY2021Q4	us-gaap	Liabilities Liabilities	299940000
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	516805000
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	1790617000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	315375000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	312946000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-309545000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39418000
CY2022Q4	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	5854000
CY2021Q4	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	273552000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	876571000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2364109000
CY2022Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	33000000.0
CY2021Q4	us-gaap	Investments In And Advances To Affiliates Balance Principal Amount InvestmentsInAndAdvancesToAffiliatesBalancePrincipalAmount	6000000.0
CY2021Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	24100000
CY2022	us-gaap	Financial Designation Predecessor And Successor Fixed List FinancialDesignationPredecessorAndSuccessorFixedList	Successor
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1049471000
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	58762000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	578602000
CY2022	piii	Medical Expenses MedicalExpenses	1057224000
CY2021Q4	piii	Medical Expenses MedicalExpenses	66877000
	piii	Medical Expenses MedicalExpenses	592465000
CY2022	piii	Premium Deficiency Testing Expense Long Duration Contract Amount1 PremiumDeficiencyTestingExpenseLongDurationContractAmount1	-11461000
CY2021Q4	piii	Premium Deficiency Testing Expense Long Duration Contract Amount1 PremiumDeficiencyTestingExpenseLongDurationContractAmount1	26277000
	piii	Premium Deficiency Testing Expense Long Duration Contract Amount1 PremiumDeficiencyTestingExpenseLongDurationContractAmount1	11559000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	157284000
CY2021Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16983000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	100243000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5096000
CY2021Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	364000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1818000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	87289000
CY2021Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7149000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1575000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1314952000
CY2022	us-gaap	Operating Expenses OperatingExpenses	2610384000
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	117650000
	us-gaap	Operating Expenses OperatingExpenses	707660000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1560913000
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-58888000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-129058000
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-11404000
CY2021Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-851000
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9824000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9865000
CY2021Q4	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2272000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	7665000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2757000
CY2021Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-471000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	147000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1218000
CY2021Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	950000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17342000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1559695000
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-57938000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-146400000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1862000
CY2022	us-gaap	Profit Loss ProfitLoss	-1561557000
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-57938000
	us-gaap	Profit Loss ProfitLoss	-146400000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1291430000
CY2021Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-47857000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-270127000
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-10081000
	us-gaap	Net Income Loss NetIncomeLoss	-146400000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.50
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.50
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41579
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41579
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41579
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41579
CY2020Q4	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	-130218000
	us-gaap	Partners Capital Account Unit Based Compensation PartnersCapitalAccountUnitBasedCompensation	1282000
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-146400000
CY2021Q4	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	-272917000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	283633000
CY2021Q4	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-10081000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	273552000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1786000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	643000
CY2022	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-270127000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5854000
CY2022	us-gaap	Profit Loss ProfitLoss	-1561557000
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-57938000
	us-gaap	Profit Loss ProfitLoss	-146400000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	87289000
CY2021Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7149000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1575000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	19404000
CY2021Q4	us-gaap	Share Based Compensation ShareBasedCompensation	4635000
	us-gaap	Share Based Compensation ShareBasedCompensation	3701000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1314952000
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1798000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	400000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9865000
CY2021Q4	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2272000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	7665000
CY2022	piii	Premium Deficiency Testing Expense Long Duration Contract Amount1 PremiumDeficiencyTestingExpenseLongDurationContractAmount1	-11461000
CY2021Q4	piii	Premium Deficiency Testing Expense Long Duration Contract Amount1 PremiumDeficiencyTestingExpenseLongDurationContractAmount1	26277000
	piii	Premium Deficiency Testing Expense Long Duration Contract Amount1 PremiumDeficiencyTestingExpenseLongDurationContractAmount1	11559000
CY2022	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	21841000
CY2021Q4	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	-3236000
	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	2770000
CY2022	piii	Increase Decrease In Clinic Fees Insurance And Other Receivables IncreaseDecreaseInClinicFeesInsuranceAndOtherReceivables	5338000
CY2021Q4	piii	Increase Decrease In Clinic Fees Insurance And Other Receivables IncreaseDecreaseInClinicFeesInsuranceAndOtherReceivables	-1467000
	piii	Increase Decrease In Clinic Fees Insurance And Other Receivables IncreaseDecreaseInClinicFeesInsuranceAndOtherReceivables	1485000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4266000
CY2021Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4704000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4254000
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-100000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6082000
CY2021Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7732000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	34224000
CY2022	piii	Increase Decrease In Accrued Payroll IncreaseDecreaseInAccruedPayroll	1920000
CY2021Q4	piii	Increase Decrease In Accrued Payroll IncreaseDecreaseInAccruedPayroll	3159000
	piii	Increase Decrease In Accrued Payroll IncreaseDecreaseInAccruedPayroll	-1134000
CY2022	piii	Increase Decrease In Insurance Settlements Payable IncreaseDecreaseInInsuranceSettlementsPayable	-8941000
CY2021Q4	piii	Increase Decrease In Insurance Settlements Payable IncreaseDecreaseInInsuranceSettlementsPayable	-2592000
	piii	Increase Decrease In Insurance Settlements Payable IncreaseDecreaseInInsuranceSettlementsPayable	11265000
CY2022	piii	Increase Decrease In Claims Payables IncreaseDecreaseInClaimsPayables	49249000
CY2021Q4	piii	Increase Decrease In Claims Payables IncreaseDecreaseInClaimsPayables	-971000
	piii	Increase Decrease In Claims Payables IncreaseDecreaseInClaimsPayables	19097000
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	5290000
CY2021Q4	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-498000
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	5216000
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	4032000
CY2021Q4	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-22000
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	306000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-126019000
CY2021Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15342000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-51129000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2233000
CY2021Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	120000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3290000
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	5500000
CY2021Q4	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	47879000
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	4989000
CY2021Q4	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	-143000
	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	-70000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7733000
CY2021Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-47856000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8209000
CY2021Q4	us-gaap	Cash Acquired In Excess Of Payments To Acquire Business CashAcquiredInExcessOfPaymentsToAcquireBusiness	195308000
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	15000000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	25000000
CY2021Q4	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	3377000
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	351000
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	46000
CY2021Q4	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	8000
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	186000
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	375000
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	3579000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11375000
CY2021Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	198677000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24790000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-122377000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	135479000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-34548000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140834000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5355000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39903000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18457000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140834000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5355000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	5714000
CY2021Q4	us-gaap	Interest Paid Net InterestPaidNet	1346000
	us-gaap	Interest Paid Net InterestPaidNet	2796000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6839000
CY2021Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	314000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4073000
CY2022	piii	Debt Issuance Warrant Issued DebtIssuanceWarrantIssued	643000
CY2022	piii	Increase In Accrued Expenses Related To Debt Issuance Costs And Original Issue Discount IncreaseInAccruedExpensesRelatedToDebtIssuanceCostsAndOriginalIssueDiscount	525000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17537000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	140478000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5301000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	920000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	356000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	54000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18457000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140834000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5355000
CY2022	us-gaap	Profit Loss ProfitLoss	-1561600000
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-57900000
	us-gaap	Profit Loss ProfitLoss	-146400000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17500000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	140500000
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><i style="text-decoration-line:underline;text-decoration-style:solid;">Management’s Use of Estimates</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Preparation of these consolidated financial statements and accompanying footnotes, in conformity with GAAP, requires management to make estimates and assumptions that could affect amounts reported here. Management bases its estimates on the best information available at the time, its experiences and various other assumptions believed to be reasonable under the circumstances, including estimates of the impact of COVID-19. See Note 21 “Commitments and Contingencies” for further discussion on the impact of COVID-19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The areas where significant estimates are used in these accompanying consolidated financial statements include revenue recognition, the liability for unpaid claims, equity-based compensation, premium deficiency reserves, fair value and impairment recognition of long-lived assets (including intangible assets and goodwill), fair value of acquired assets and liabilities in business combinations, fair value of liability classified instruments, and judgments related to deferred income taxes. Actual results could differ from those estimates.</p>
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	842835000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	91785000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	751050000
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17500000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	140500000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	900000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	400000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1049471000
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	58762000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	578602000
CY2022Q4	piii	Number Of Health Plans Percentage Of Payment Contracts Entered NumberOfHealthPlansPercentageOfPaymentContractsEntered	4
CY2022Q4	piii	Additional Revenue Related To Prior Year Premium Risk Adjustments AdditionalRevenueRelatedToPriorYearPremiumRiskAdjustments	3300000
CY2021Q4	piii	Additional Revenue Related To Prior Year Premium Risk Adjustments AdditionalRevenueRelatedToPriorYearPremiumRiskAdjustments	0
CY2022	piii	Health Plans Term Of Contract HealthPlansTermOfContract	P1M
CY2022Q4	piii	Major Customers Number MajorCustomersNumber	3
CY2021Q4	piii	Major Customers Number MajorCustomersNumber	2
CY2022Q4	piii	Patient Fees Receivable Current PatientFeesReceivableCurrent	800000
CY2021Q4	piii	Patient Fees Receivable Current PatientFeesReceivableCurrent	700000
CY2022Q4	piii	Patient Fees Receivable Contractual Allowance Current PatientFeesReceivableContractualAllowanceCurrent	5800000
CY2021Q4	piii	Patient Fees Receivable Contractual Allowance Current PatientFeesReceivableContractualAllowanceCurrent	2000000.0
CY2022	us-gaap	Advertising Expense AdvertisingExpense	4500000
CY2021Q4	us-gaap	Advertising Expense AdvertisingExpense	300000
	us-gaap	Advertising Expense AdvertisingExpense	1800000
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	5202000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1314952000
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	1314952000
CY2022	piii	Maximum Percentage Of Utilization Of Operating Loss Carryforwards Of Taxable Income MaximumPercentageOfUtilizationOfOperatingLossCarryforwardsOfTaxableIncome	0.80
CY2022Q4	piii	Premium Deficiency Reserve Current PremiumDeficiencyReserveCurrent	26400000
CY2021Q4	piii	Premium Deficiency Reserve Current PremiumDeficiencyReserveCurrent	37800000
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reclassifications</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Certain amounts in the consolidated balance sheet as of December 31, 2021 and the consolidated statements of operations and cash flows for the Successor Period of 2021 and Predecessor Period of 2021 have been reclassified to be consistent with the current period presentation. These reclassifications were to (i) present notes receivable, net and right-of-use asset collectively as other long-term assets on the consolidated balance sheet; (ii) separately present accounts payable from accrued expenses and other current liabilities on the consolidated balance sheet; (iii) present depreciation expense and amortization of intangible assets collectively as depreciation and amortization expense on the consolidated statements of operations and cash flows; (iv) present amortization of debt origination fees and amortization of discount from issuance of debt collectively as amortization of original issue discount and debt issuance costs on the consolidated statements of cash flows; and (v) present payment of debt issuance costs separately from debt proceeds on the consolidated statements of cash flows. The reclassifications had no impact on the Company’s financial condition, results of operations, or net cash flows.</p>
CY2021Q4	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	3800000
CY2021Q4	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y
CY2021	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	793447000
CY2021	us-gaap	Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax	-259282000
CY2021	piii	Business Acquisition Pro Forma Net Income Loss Attributable To Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossAttributableToNoncontrollingInterest	-214167000
CY2021	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-45115000
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	1314952000
CY2022Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	851500000
CY2022Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	463500000
CY2021Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11460000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8230000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2621000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	182000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8839000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8048000
CY2022	us-gaap	Depreciation Depreciation	2400000
CY2021Q4	us-gaap	Depreciation Depreciation	200000
	us-gaap	Depreciation Depreciation	1500000
CY2021Q4	us-gaap	Goodwill Gross GoodwillGross	1278453000
CY2021Q4	us-gaap	Goodwill Goodwill	1278453000
CY2021Q4	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	31297000
CY2021Q4	us-gaap	Goodwill Gross GoodwillGross	1309750000
CY2021Q4	us-gaap	Goodwill Goodwill	1309750000
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	842800000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6961000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	835839000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	84800000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7000000.0
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	84600000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	84200000
CY2022Q4	piii	Notes Receivable Noncurrent NotesReceivableNoncurrent	3500000
CY2021Q4	piii	Notes Receivable Noncurrent NotesReceivableNoncurrent	3600000
CY2022Q4	us-gaap	Financing Receivable Accrued Interest Before Allowance For Credit Loss FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss	1000000.0
CY2021Q4	us-gaap	Financing Receivable Accrued Interest Before Allowance For Credit Loss FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss	900000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	700000
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	500000
CY2022	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	300000
CY2021	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	100000
CY2022	us-gaap	Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Claims unpaid, beginning of period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 101,958</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 76,031</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Incurred, related to:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;"></span></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Current period</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 942,570</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 55,149</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Prior period(s)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 882</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 174</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Total incurred</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 943,452</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 55,323</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Paid, related to:</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;"></span></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Current period</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 794,026</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 53,366</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Prior period(s)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 100,177</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 2,928</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Total paid</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 894,203</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 56,294</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Claims unpaid assumed in acquisitions</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;">—</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 26,898</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Claims unpaid, end of period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 151,207</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 101,958</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p>
CY2021Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	101958000
CY2020Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	76031000
CY2022	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	942570000
CY2021	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	55149000
CY2022	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	882000
CY2021	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	174000
CY2022	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	943452000
CY2021	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	55323000
CY2022	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	794026000
CY2021	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	53366000
CY2022	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	100177000
CY2021	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	2928000
CY2022	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	894203000
CY2021	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	56294000
CY2021Q4	piii	Liability For Unpaid Claims Assumed In Acquisitions LiabilityForUnpaidClaimsAssumedInAcquisitions	26898000
CY2022Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	151207000
CY2021Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	101958000
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	95000000
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	80046000
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	579000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	94421000
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	80046000
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	46000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	94421000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	80000000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	65000000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	30000000
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	95000000
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	579000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	94421000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1559695000
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-57938000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-146400000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1559695000
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-57938000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-146400000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	111000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1751000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1862000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1862000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-327536000
CY2021Q4	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-12166000
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-30744000
CY2022	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	-260020000
CY2021Q4	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	-8359000
	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	-30744000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	33961000
CY2021Q4	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2832000
CY2022	piii	Income Tax Reconciliation Tax Credits Investment In P3 Llc IncomeTaxReconciliationTaxCreditsInvestmentInP3Llc	35147000
CY2021Q4	piii	Income Tax Reconciliation Tax Credits Investment In P3 Llc IncomeTaxReconciliationTaxCreditsInvestmentInP3Llc	1550000
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	270000
CY2021Q4	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-575000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1862000
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2022Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	20684
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	17601
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6922
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	2764
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	3307
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	589
CY2022Q4	piii	Deferred Tax Assets Interest Limitation DeferredTaxAssetsInterestLimitation	1995
CY2021Q4	piii	Deferred Tax Assets Interest Limitation DeferredTaxAssetsInterestLimitation	1232
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	94
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	43727
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11464
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	43558
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9621
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	169
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1843
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	150
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	87
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	19
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	1756
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	169
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1843
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	31400000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	2400000
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-270127000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-270127000
CY2021Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10081000
CY2021Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10081000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41579
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41579
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41579
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41579
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.50
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.50
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10819105
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	216622
CY2021Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	212844
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11700000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7000000.0
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y2M19D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y3D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.117
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.111
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1082000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3212000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3382000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2836000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2599000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	6539000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	19650000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6860000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	12790000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1600000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2100000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	3339000
CY2021Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	255000
	us-gaap	Operating Lease Payments OperatingLeasePayments	2256000
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	800000
CY2021Q4	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0
CY2021	piii	Redeemable Noncontrolling Interest Equity Fair Value Remeasurement Adjustment RedeemableNoncontrollingInterestEquityFairValueRemeasurementAdjustment	0
CY2022	piii	Redeemable Noncontrolling Interest Equity Fair Value Remeasurement Adjustment RedeemableNoncontrollingInterestEquityFairValueRemeasurementAdjustment	0
CY2021	piii	Number Of Health Plans Resulting In Renegotiation NumberOfHealthPlansResultingInRenegotiation	1
CY2022	piii	Percentage Of Total Revenues Recurring PercentageOfTotalRevenuesRecurring	0.99
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11248285

Files In Submission

Name	View Source	Status
0001104659-23-039643-index-headers.html	Edgar Link	pending
0001104659-23-039643-index.html	Edgar Link	pending
0001104659-23-039643.txt	Edgar Link	pending
0001104659-23-039643-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
piii-20221231.xsd	Edgar Link	pending
piii-20221231x10k.htm	Edgar Link	pending
piii-20221231x10k001.jpg	Edgar Link	pending
piii-20221231x10k002.jpg	Edgar Link	pending
piii-20221231xex21d1.htm	Edgar Link	pending
piii-20221231xex23d1.htm	Edgar Link	pending
piii-20221231xex31d1.htm	Edgar Link	pending
piii-20221231xex31d2.htm	Edgar Link	pending
piii-20221231xex32d1.htm	Edgar Link	pending
piii-20221231xex32d2.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
piii-20221231_pre.xml	Edgar Link	unprocessable
piii-20221231_def.xml	Edgar Link	unprocessable
piii-20221231_lab.xml	Edgar Link	unprocessable
piii-20221231_cal.xml	Edgar Link	unprocessable
piii-20221231x10k_htm.xml	Edgar Link	completed
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PIII
P3 Health Partners Inc. Stock $piii

2022 Q4 Form 10-K Financial Statement

#000110465923039643 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PIII P3 Health Partners Inc. Stock $piii

2022 Q4 Form 10-K Financial Statement

#000110465923039643 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PIII
P3 Health Partners Inc. Stock $piii